This study will assess the feasibility of using the OnLume Imaging System for
fluorescence-guided surgery along with indocyanine green (ICG) dye in the operating room for
the axillary reverse mapping (ARM) procedure in women with breast cancer scheduled to have
axillary dissection (AD) or sentinel lymph node (SLN) biopsy.
Phase:
N/A
Details
Lead Sponsor:
University of Wisconsin, Madison
Collaborators:
National Cancer Institute (NCI) National Institutes of Health (NIH) OnLume Inc.